title: Longitudinal seizure outcome and prognostic predictors after hemispherectomy in 170 children.
abstract: OBJECTIVE
  Data on longitudinal seizure outcome after hemispherectomy in children are limited. This study explores the posthemispherectomy longitudinal seizure outcome and its predictors.
  
  
  METHODS
  We reviewed 186 consecutive children who underwent hemispherectomy between 1997 and 2009 at our center. Clinical, EEG, imaging, and surgical data were collected. Seizure outcome data were collected via a structured questionnaire by contacting families (n = 125) or from the medical records at last follow-up (n = 58).
  
  
  RESULTS
  Of 186 patients, 3 were lost to follow-up; 13 seizure-free patients with new-onset nonepileptic spells were excluded. Perioperative complications were not collected. There was no mortality. At a mean follow-up of 5.3 years (±3.3 years), 112 of 170 children (66%) were seizure-free (Engel class 1a). In 58 patients with seizure recurrence, 8 had late remission and 16 had >90% reduction. Overall, at last follow-up, 136 patients (80%) were either seizure-free or had major improvement. Using survival analysis, the estimated probability of seizure freedom after hemispherectomy was 78% (95% confidence interval [CI] = 75%-81%) at 6 months, 76% (95% CI = 73%-79%) at 1 year, 71% (95% CI = 68%-74%) at 2 years, and 63% (95% CI = 59%-67%) at 5 years. On multivariate analysis, bilateral PET abnormalities (risk ratio = 2.53, 95% CI = 1.02-5.85) and acute postoperative seizures (risk ratio = 7.03, 95% CI = 3.07-15.9) independently predicted seizure recurrence.
  
  
  CONCLUSIONS
  The long-term seizure-free rates after hemispherectomy remained stable at 63% at 5 years and beyond. This study will assist in better candidate selection for hemispherectomy, presurgical counseling, and early identification of surgical failures.
authors.affiliation: Department of Neurology, Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: Ahsan N V
authors.initials: AN
authors.lastname: Moosa
authors.forename: Ajay
authors.initials: A
authors.lastname: Gupta
authors.forename: Lara
authors.initials: L
authors.lastname: Jehi
authors.forename: Ahmad
authors.initials: A
authors.lastname: Marashly
authors.forename: Gary
authors.initials: G
authors.lastname: Cosmo
authors.forename: Deepak
authors.initials: D
authors.lastname: Lachhwani
authors.forename: Elaine
authors.initials: E
authors.lastname: Wyllie
authors.forename: Prakash
authors.initials: P
authors.lastname: Kotagal
authors.forename: William
authors.initials: W
authors.lastname: Bingaman
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004569:Electroencephalography; D004827:Epilepsy / Q000473:pathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D038421:Hemispherectomy; D006801:Humans; D053208:Kaplan-Meier Estimate; D008137:Longitudinal Studies; D008279:Magnetic Resonance Imaging; D008297:Male; D015999:Multivariate Analysis; D049268:Positron-Emission Tomography; D011237:Predictive Value of Tests; D011379:Prognosis; D012008:Recurrence; D012640:Seizures / Q000453:epidemiology / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants